Erlotinib Tablets IP 150 mg

Erlocip 150 mg, manufactured by Cipla, contains Erlotinib (Erlotinib 100 mg Tablet) as an active ingredient. Erlotinib Hydrochloride Tablets is a tyrosine kinase inhibitor that comes under the strengths of 100 mg and 150 mg in each tablet. Erlocip tablet works by helping to stop cancer cells from growing. Erlotinib 100 mg tablet highly prescribed the drug for treating certain types of advanced or metastatic lung cancer. Erlotinib 150 is also used to treat certain types of pancreatic cancer in combination with another medicine. We also have in stock Erlocip 100 mg (Erlotinib) which is used to treat the same indications.